TELO today
$0.36-$0.08 (-17.24%)close Nov 20, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minSymmetric Triangle
5 minStrong Bearish
Daily trend turns up above $1.50
Key levels
Resistance$1.07
Resistance$0.96
Latest news & SEC filings
DealTelo Genomics to Raise Funds via Secured Convertible Debentures
DealTelo Genomics Reaches Preliminary Deal to License AI Tech Exclusively
ProductTelomir Pharmaceuticals taps Linical for Telomir-Zn Phase 1/2 study
All TELO news →About Telomir Pharmaceuticals
Telomir Pharmaceuticals develops experimental small-molecule drugs aimed at the underlying biology of aging and related illnesses. Its main candidate, Telomir-1, is taken by mouth and is intended to control levels of metals such as iron and copper inside cells; it is being tested in laboratory and animal models for Wilson's disease, Type 2 diabetes, macular degeneration, progeria, and several cancers. The firm is based in the United States and has not yet started testing in people.
Based on the company's 10-K filed Mar 17, 2026.
Nasdaq · Healthcare
Telomir Pharmaceuticals, Inc. (TELO)
What Is the Price Target for TELO?
SEPT Low Target
$4.00
SEPT Mid Target
$4.00
SEPT High Target
$4.00
Analyst Consensus
$4.00
Is TELO a Buy or Sell Right Now?
Thesis
Test your own strategy on TELO
Describe your strategy in plain words, then scan, alert, backtest and paper trade it on TELO with SEPT’s own market data.
Start Free Trial →Is TELO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$3.05
12
Moat Score
NONE
4/9
Piotroski Score
4.8
Altman Z-Score
What Is Smart Money Doing with TELO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See Smart Money Data →TELO Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
41.07%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for TELO
PREVIEWRecent off-exchange (dark pool) prints for TELO: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:43 | $0.37 | 5,000 | $$2K | BUY |
| 20:59:20 | $0.36 | 2,500 | $$911 | BUY |
| 20:59:14 | $0.36 | 2,475 | $$886 | SELL |
| 20:37:25 | $0.44 | 3,000 | $$1K | BUY |
| 20:19:51 | $0.38 | 3,200 | $$1K | BUY |
5 dark pool trades shown · $$6K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Telomir Pharmaceuticals, Inc. (TELO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Your strategy, tested before real money.
Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.
Try SEPT Free for 7 Days →TELO — frequently asked questions
What is TELO stock price today?
Telomir Pharmaceuticals, Inc. (TELO) is at $0.36, down 17.24% (-$0.08) at the Nov 20, 2026 close.
Why is TELO stock moving today?
Latest TELO news — Nov 21, 2026: Telo Genomics to Raise Funds via Secured Convertible Debentures · Nov 19, 2026: Telo Genomics Reaches Preliminary Deal to License AI Tech Exclusively
What is the TELO price target?
The average analyst price target for TELO is $4.00, ranging from $4 to $4, based on 1 analysts. Latest: Maxim Group initiates on Sep 17, 2026.
What do analysts rate TELO?
Analyst ratings for TELO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did TELO beat earnings?
TELO last reported on Aug 13, 2026: EPS -$0.79 vs -$0.07 expected — a miss of 1028.6%.
What are TELO support and resistance levels?
Resistance: $0.96, $1.07, $1.20.
What are insiders doing with TELO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on TELO?
Nov 21, 2026: Telo Genomics to Raise Funds via Secured Convertible Debentures · Nov 19, 2026: Telo Genomics Reaches Preliminary Deal to License AI Tech Exclusively · Nov 18, 2026: Telomir Pharmaceuticals taps Linical for Telomir-Zn Phase 1/2 study